Skip to main content
. 2018 May;10(5):2691–2699. doi: 10.21037/jtd.2018.05.17

Figure 1.

Figure 1

OS rates of the 42 patients who underwent resection for recurrent or residual tumours were compared according to the therapy used to treat the primary tumour. dCRT, definitive chemoradiotherapy; OS, overall survival.